PPARγ partial agonist LPSF/GQ-16 prevents dermal and pulmonary fibrosis in HOCl-induced systemic sclerosis (SSc) and modulates cytokine production in PBMC of SSc patients - Almeida, Anderson Rodrigues de; Dantas, Andréa Tavares; Gonçalves, Maria Eduarda de Oliveira; Chêne, Charlotte; Jeljeli, Mohamed; Chouzenoux, Sandrine; Thomas, Marine; Cunha, Eudes Gustavo Constantino; Valadares, Lilian David de Azevedo; Gomes, João Victor de Melo; Paula, Simão Kalebe Silva de; Pitta, Marina Galdino da Rocha; et al. (Inflammopharmacology, 2024)